Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 4 of 6 (67%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §102 only | 2 (33%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HASAN, KHALEDA B | 1 | 58.6% | +49.3% |
| EBBINGHAUS, BRIANA NOEL | 1 | 57.4% | +67.0% |
| HILL, KEVIN KAI | 1 | 36.2% | +33.4% |
| MCLEOD, AFRICA MHAIRIE | 1 | 44.7% | +68.6% |
| MCCORMICK, CATHERINE LYNN | 1 | 46.9% | +21.8% |
| BATES, KEENAN ALEXANDER | 1 | 46.3% | +70.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17632026 | DUX4 EXPRESSING CELLS AND USES THEREOF | BATES, KEENAN ALEXANDER | 45d overdue |
| 18031771 | HEPATOCYTE-LIKE CELLS | EBBINGHAUS, BRIANA NOEL | 19d overdue |
| 17792121 | MODIFICATION OF BLOOD TYPE ANTIGENS | MCLEOD, AFRICA MHAIRIE | 4d overdue |
| 18449625 | GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY | HASAN, KHALEDA B | 19d |
| 17637789 | CD24 EXPRESSING CELLS AND USES THEREOF | MCCORMICK, CATHERINE LYNN | 63d |
| 17997103 | REPEAT DOSING OF HYPOIMMUNOGENIC CELLS | HILL, KEVIN KAI | 70d |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1636 | 1 |
| 1632 | 1 |
| 1635 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18449625 | GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY | HASAN, KHALEDA B | 1636 | §102 | Final Rejection | 19d | Pending | Aug 14, 2023 |
| 18031771 | HEPATOCYTE-LIKE CELLS | EBBINGHAUS, BRIANA NOEL | 1632 | §103 | Non-Final OA | 19d overdue | AI Ready | Apr 13, 2023 |
| 17997103 | REPEAT DOSING OF HYPOIMMUNOGENIC CELLS | HILL, KEVIN KAI | 1638 | §103 | Non-Final OA | 70d | Pending | Oct 25, 2022 |
| 17792121 | MODIFICATION OF BLOOD TYPE ANTIGENS | MCLEOD, AFRICA MHAIRIE | 1635 | §103 | Final Rejection | 4d overdue | AI Ready | Jul 11, 2022 |
| 17637789 | CD24 EXPRESSING CELLS AND USES THEREOF | MCCORMICK, CATHERINE LYNN | 1638 | §102 | Final Rejection | 63d | AI Ready | Feb 23, 2022 |
| 17632026 | DUX4 EXPRESSING CELLS AND USES THEREOF | BATES, KEENAN ALEXANDER | 1631 | Other | Final Rejection | 45d overdue | AI Ready | Feb 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial